IN2014MN02526A - - Google Patents

Info

Publication number
IN2014MN02526A
IN2014MN02526A IN2526MUN2014A IN2014MN02526A IN 2014MN02526 A IN2014MN02526 A IN 2014MN02526A IN 2526MUN2014 A IN2526MUN2014 A IN 2526MUN2014A IN 2014MN02526 A IN2014MN02526 A IN 2014MN02526A
Authority
IN
India
Prior art keywords
medicament
core
active ingredient
provision
intermediate layer
Prior art date
Application number
Other languages
English (en)
Inventor
Gernot Francas
Karl Heinz PRZYKLENK
Original Assignee
Hennig Arzneimittel Gmbh & Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hennig Arzneimittel Gmbh & Co filed Critical Hennig Arzneimittel Gmbh & Co
Publication of IN2014MN02526A publication Critical patent/IN2014MN02526A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IN2526MUN2014 2012-06-25 2013-06-24 IN2014MN02526A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102012105528.9A DE102012105528A1 (de) 2012-06-25 2012-06-25 Arzneiform zur Freisetzung von Wirkstoffen
PCT/EP2013/063162 WO2014001267A2 (de) 2012-06-25 2013-06-24 Arzneiform zur freisetzung von wirkstoffen

Publications (1)

Publication Number Publication Date
IN2014MN02526A true IN2014MN02526A (pt) 2015-07-17

Family

ID=48656002

Family Applications (1)

Application Number Title Priority Date Filing Date
IN2526MUN2014 IN2014MN02526A (pt) 2012-06-25 2013-06-24

Country Status (20)

Country Link
EP (2) EP2863896B1 (pt)
AU (1) AU2013283473B2 (pt)
BR (1) BR112014032578B1 (pt)
CA (1) CA2877190C (pt)
CO (1) CO7250447A2 (pt)
DE (1) DE102012105528A1 (pt)
DK (1) DK2679216T3 (pt)
EA (1) EA030871B1 (pt)
ES (2) ES2546172T3 (pt)
HU (2) HUE031246T2 (pt)
IL (1) IL236466B (pt)
IN (1) IN2014MN02526A (pt)
MX (1) MX367284B (pt)
MY (1) MY168531A (pt)
PH (1) PH12014502836B1 (pt)
PL (2) PL2863896T3 (pt)
PT (2) PT2679216E (pt)
UA (1) UA118836C2 (pt)
WO (1) WO2014001267A2 (pt)
ZA (1) ZA201409506B (pt)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2936748C (en) 2014-10-31 2017-08-08 Purdue Pharma Methods and compositions particularly for treatment of attention deficit disorder
PT3431078T (pt) 2017-07-20 2021-04-21 Intas Pharmaceuticals Ltd Composições orais sólidas de libertação prolongada não pulsáteis de betaistina
US10722473B2 (en) 2018-11-19 2020-07-28 Purdue Pharma L.P. Methods and compositions particularly for treatment of attention deficit disorder
DE102018129419A1 (de) 2018-11-22 2020-05-28 Johannes Gutenberg-Universität Mainz Acrylat-Copolymer für galenische Anwendungen

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4503031A (en) * 1982-12-17 1985-03-05 Glassman Jacob A Super-fast-starting-sustained release tablet
IT1229237B (it) * 1989-05-08 1991-07-26 Prodotti Formenti Sali di (2-(piridil)etil) metilammina
EP0584594B1 (de) * 1992-08-06 1998-04-01 Gerhard Dr. Gergely Leicht einnehmbare brausende Manteltablette
HRP970493A2 (en) 1996-09-23 1998-08-31 Wienman E. Phlips Oral delayed immediate release medical formulation and method for preparing the same
US6419960B1 (en) * 1998-12-17 2002-07-16 Euro-Celtique S.A. Controlled release formulations having rapid onset and rapid decline of effective plasma drug concentrations
IT1309591B1 (it) 1999-03-05 2002-01-24 Formenti Farmaceutici Spa Composizioni a rilascio controllato di betaistina.
DE10010509A1 (de) 2000-03-08 2001-09-13 Dresden Arzneimittel Pharmazeutische Formulierungen
DE10104880A1 (de) 2001-01-31 2002-08-08 Roehm Gmbh Multipartikuläre Arzneiform, enthaltend mindestens zwei unterschiedlich überzogene Pelletformen
DE60320965D1 (de) * 2003-07-04 2008-06-26 Formenti Farmaceutici Spa Betahistinezubereitungen mit kontrollierter Freisetzung
US20060280795A1 (en) * 2005-06-08 2006-12-14 Dexcel Pharma Technologies, Ltd. Specific time-delayed burst profile delivery system
JP2010523554A (ja) * 2007-04-04 2010-07-15 シグモイド・ファーマ・リミテッド タクロリムスの医薬組成物
EP2675435A1 (en) * 2011-02-17 2013-12-25 Lupin Limited Sustained release composition of memantine

Also Published As

Publication number Publication date
DK2679216T3 (en) 2015-08-31
AU2013283473A2 (en) 2015-01-22
PT2863896T (pt) 2016-12-21
PL2679216T3 (pl) 2015-12-31
EP2863896A2 (de) 2015-04-29
MX2014015660A (es) 2015-07-14
HUE031246T2 (en) 2017-06-28
EP2679216B1 (de) 2015-05-27
CA2877190A1 (en) 2014-01-03
EP2679216A1 (de) 2014-01-01
PH12014502836A1 (en) 2015-02-02
BR112014032578B1 (pt) 2022-07-26
UA118836C2 (uk) 2019-03-25
HUE025739T2 (en) 2016-04-28
EP2863896B1 (de) 2016-09-14
DE102012105528A1 (de) 2014-01-02
ES2607447T3 (es) 2017-03-31
PL2863896T3 (pl) 2017-04-28
AU2013283473A1 (en) 2015-01-29
WO2014001267A2 (de) 2014-01-03
EA201500044A1 (ru) 2015-05-29
MX367284B (es) 2019-08-13
EA030871B1 (ru) 2018-10-31
ES2546172T3 (es) 2015-09-21
BR112014032578A2 (pt) 2017-06-27
IL236466B (en) 2019-02-28
CA2877190C (en) 2020-01-07
ZA201409506B (en) 2016-08-31
MY168531A (en) 2018-11-12
PH12014502836B1 (en) 2015-02-02
IL236466A0 (en) 2015-02-26
AU2013283473B2 (en) 2016-10-27
PT2679216E (pt) 2015-10-09
CO7250447A2 (es) 2015-04-30
WO2014001267A3 (de) 2014-03-06

Similar Documents

Publication Publication Date Title
MX2019007956A (es) Liberacion autorregulada de ingrediente farmaceutico activo.
MX350875B (es) Formas de dosificacion farmaceutica de liberacion controlada.
WO2013158680A3 (en) Compositions and methods comprising celecoxib or related compounds and dextromethorphan
WO2014205229A8 (en) Use of high dose pridopidine for treating huntington's disease
IN2014DN10548A (pt)
MY181159A (en) Sublingual and buccal film compositions
PH12020550806A1 (en) Core tablet composite preparation comprising mosapride and rabeprazole
PH12014501408A1 (en) Immediate release multi unit pellet system
MY165888A (en) Dry powder formulation comprising a corticosteroid and a beta-adrenergic for administration by inhalation
PH12014502836B1 (en) Medicament form for release of active ingredients
WO2013058484A3 (ko) 인제난 타입의 디테르펜 화합물 및 이를 포함하는 바이러스 감염 질환의 치료 또는 예방용 약학적 조성물
PH12015500653B1 (en) Combination drug comprising gemigliptin and metformin, and method for the preparation thereof
MX2011007779A (es) Formulaciones galenicas de compuestos organicos.
MX2017013636A (es) Combinacion de dosis fija resistente a la manipulacion que proporciona una liberacion rapida de dos farmacos desde diferentes particulas.
MX2016008027A (es) Uso de laquinimod para retrasar la evolucion de la enfermedad de huntington.
WO2016108572A3 (ko) 콜레스테롤 관련 질환의 예방 및 치료용 조성물
WO2012102645A3 (en) Pharmaceutical composition comprising the peptide glu-asp-gly and use for treating helicobacter pylori induced gastroduodenal diseases
UA108277C2 (ru) Комплексный препарат, содержащий лерканидипина гидрохлорид и валсартан, и способ его получения
MX2017013633A (es) Combinacion de dosis fija resistente a la manipulacion que proporciona una liberacion rapida de dos farmacos desde particulas.
TW201613606A (en) Therapeutic drug for chronic renal failure
WO2014129884A3 (en) Composition with inhibitory effect on viral integrase activity
WO2012111961A3 (ko) 티아넵틴 또는 이의 약제학적으로 허용되는 염을 포함하는 경구투여용 서방성 정제
JP2013079218A5 (pt)
WO2012033348A3 (ko) 2-리놀레오일 글리세롤을 포함하는 알러지성 질환의 예방 또는 치료용 조성물
WO2013035053A3 (en) Novel conjugation-facilitated transport of drugs across blood brain barrier